Loading provider…
Loading provider…
Hematology & Oncology Physician in Augusta, GA
NPI: 1073775722Primary Practice Location
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
1120 15th St, Augusta, GA
Primary Employer
Wellstar Medical Group, LLC
wellstar.org
HQ Phone
Get MD Jigarkumar's Phone Numberphone_androidMobile
Get MD Jigarkumar's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 296 | 787 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 162 | 417 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 67 | 84 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 59 | 59 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 44 | 153 |
Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition.
Authors: Sodji, Quaovi, Klein, Kandy, Sravan, Kavuri, Parikh, Jigarkumar
Journal: J Immunother Cancer
Publication Date: 2017-08-15
Authors: Cole Giller, Thomas Samuel, Anand Jillella
Journal: J Neurol Surg A Cent Eur Neurosurg
Publication Date: 2013-02-20
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Cabozantinib, DRUG: CB-839
Lead Sponsor: Innocrin Pharmaceutical
Intervention / Treatment: DRUG: Seviteronel
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: placebo, DRUG: capecitabine, DRUG: tucatinib, DRUG: trastuzumab